Our results manifested that higher BGN expression was linked to poorer overall survival (OS) in patients with colon cancer in TCGA (p = 0.007) and GSE17536 dataset (p < 0.001) (Figures 3A, D). Here, BGN is linked to malignant colon neoplasm.